Marker Therapeutics Ratios (2010-2026) | MRKR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
EBT Margin (Quarter)				-1,015.39%	-661.95%	-572.92%	1,674.09%	-168.99%	814.90%	-1,157.57%	-259.00%	-192.34%	-109.63%	-119.84%	225.94%	-1,373.60%	-479.92%	-162.11%	780.69%
EBIT Margin (Quarter)				-1,015.71%	-666.47%	-582.90%	1,659.68%	-172.38%	821.87%	-1,242.22%	-278.06%	-204.89%	-115.40%	-124.60%	222.66%	-1,420.14%	-494.79%	-173.30%	765.68%
EBITDA Margin (Quarter)				-1,015.71%	-666.47%	-582.90%	1,659.68%	-172.38%	821.87%	-1,242.22%	-278.06%	-204.89%	-115.40%	-124.60%	222.66%	-1,420.14%	-494.79%	-173.30%	765.68%
Operating Margin (Quarter)				-1,015.71%	-666.47%	-582.90%	1,659.68%	-172.38%	821.87%	-1,242.22%	-278.06%	-204.89%	-115.40%	-124.60%	222.66%	-1,420.14%	-494.79%	-173.30%	765.68%
Net Margin (Quarter)				-1,015.39%	-507.45%	-119.34%	-107.10%	-29.71%	-1,315.05%		-5.96%	-192.34%	-109.63%	-119.84%	225.94%	-1,373.60%	-479.92%	-162.11%	780.69%
FCF Margin (Quarter)				-1,509.31%	300.39%	-531.44%	-1,256.37%	-129.61%	1,957.58%	1,905.43%	-795.39%	-308.43%	-178.38%	62.17%	-208.86%	-1,575.39%	-218.11%	-221.90%	-172.20%
Efficiency
Assets Average (Quarter)	84.42M	76.21M	70.04M	61.55M	53.64M	46.72M	37.77M	31.18M	24.95M	20.72M	18.31M	15.61M	12.88M	11.29M	16.47M	19.51M	15.88M	18.25M	20.40M	18.25M
Equity Average (Quarter)	67.87M	57.76M	48.13M	39.85M	31.87M	25.31M	21.10M	17.76M	17.47M	17.87M	15.38M	12.92M	10.75M	8.58M	13.00M	16.53M	12.49M	14.44M	17.59M	15.30M
Invested Capital (Quarter)	63.24M	52.28M	43.99M	35.71M	36.03M	27.65M	22.10M	15.91M	19.03M	16.71M	14.05M	11.79M	9.70M	7.45M	18.56M	14.49M	10.49M	18.39M	16.80M	13.80M
Asset Utilization Ratio (Quarter)				0.02	0.03	0.06	0.09	0.16	0.15	0.15	0.18	0.13	0.35	0.55	0.45	0.33	0.34	0.26	0.17
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)					0.29	0.22	0.13	0.01
Debt Ratio (Quarter)					0.15	0.12	0.07	0.00
Equity Ratio (Quarter)	0.79	0.73	0.65	0.65	0.54	0.55	0.57	0.57	0.87	0.86	0.82	0.84	0.83	0.68	0.84	0.85	0.71	0.85	0.88	0.79
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)	-57.20M	-48.70M	-43.50M	-28.82M	-25.80M	-18.08M	-11.78M	-6.40M	-18.10M	-17.47M	-15.11M	-11.32M	-7.80M	-9.00M	-19.19M	-13.69M	-11.81M	-18.99M	-17.04M	-15.62M
Return Ratios
Return on Sales (Quarter)				-0.10%	-0.05%	-0.01%	-0.01%	0.00%	-0.13%	0.02%	0.00%	-0.02%	-0.01%	-0.01%	0.02%	-0.14%	-0.05%	-0.02%	0.08%
Return on Capital Employed (Quarter)	-45.17%	-56.23%	-69.09%	-75.93%	-86.77%	-86.52%	-27.65%	-10.80%	-7.58%	5.33%	-95.73%	-96.35%	-100.77%	-130.17%	-17.25%	-27.35%	-56.92%	-42.55%	-16.03%	-13.83%
Return on Assets (Quarter)	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Marker Therapeutics Ratios (2010-2026) | MRKR

Research Tools

Developers

Marker Therapeutics Ratios (2010-2026) | MRKR

Create an account

Sign In

Reset Password